Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Terminated 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 6Head & Neck 2Gastrointestinal 2Thoracic 1Gynecologic 1Breast 1

Conditions

Triple Negative Breast Neoplasms 163Breast Neoplasms 162Carcinoma, Non-Small-Cell Lung 60Melanoma 44Ovarian Neoplasms 42Colorectal Neoplasms 37Carcinoma, Renal Cell 36Squamous Cell Carcinoma of Head and Neck 33Pancreatic Neoplasms 29Stomach Neoplasms 28Neoplasm Metastasis 27Uterine Cervical Neoplasms 24Neoplasms 24Endometrial Neoplasms 24Lung Neoplasms 19Head and Neck Neoplasms 19Esophageal Neoplasms 18Carcinoma, Transitional Cell 18Carcinoma, Hepatocellular 16Urinary Bladder Neoplasms 14Small Cell Lung Carcinoma 14Prostatic Neoplasms 14Parkinson Disease 4, Autosomal Dominant Lewy Body 13Sarcoma 10Mesothelioma 9Kidney Neoplasms 9Cholangiocarcinoma 9Carcinoma, Ovarian Epithelial 9Carcinoma, Merkel Cell 9Fallopian Tube Neoplasms 8

Interventions

Ipilimumab 2pembrolizumab 1montanide ISA 51 1futibatinib 1fludarabine 1belinostat 1aldesleukin 1Ritonavir 1Radiotherapy 1Nivolumab 1Mass Spectrometry 1Interleukin-2 1Indinavir 1Fluorouracil 1Erlotinib Hydrochloride 1Cyclophosphamide 1Chromatography, High Pressure Liquid 1CTLA-4 Antigen 1BI 2536 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Histiocytoma, Malignant Fibrous × pembrolizumab × Breast × Clear all
NCT04099277 2021-08-31

A Study of LY3435151 in Participants With Solid Tumors

Eli Lilly and Company

Phase 1 Terminated
2 enrolled 8 charts
BreastGastrointestinalGynecologicHead & NeckSarcoma

Squamous Cell Carcinoma of Head and Neck, Uterine Cervical Neoplasms, Carcinoma, Hepatocellular, Leiomyosarcoma, Histiocytoma, Malignant Fibrous, Triple Negative Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡